Blanket Purchase Agreement W81K0020A0014
Award Date
10/1/20
Last Date to Order
9/30/25
Federal Agency
Medical Command
Awardee
Pharmalucence, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmarx Hawaii LLC on May 1, 2021. The potential value of the contract is $1,250,000. Orders may be placed through April 30, 2026 to procure radiopharmaceutical supplies in support of Tripler Army Medical Center in Hawaii.
The contract aims to provide a wide range of medical isotopes and radiopharmaceuticals used in nuclear medicine imaging and therapeutic procedures. Common radiotracers such as...
The Defense Health Agency (DHA) has awarded a Blanket Purchase Agreement (BPA) to Medi-Physics, Inc., a subsidiary of General Electric Company (GE), to provide radiopharmaceuticals and supplies to military treatment facilities nationwide. The contract has a potential value of $1 million and a period of performance from October 1, 2020 through September 30, 2025.
Under this BPA, Medi-Physics will deliver a range of radioactive tracers, medical isotopes, and diagnostic imaging agents used in...
The Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmalucence, Inc. as a single-award contract with a potential value of $1,250,000. The BPA aims to procure radiopharmaceutical supplies for Tripler Army Medical Center in Hawaii over a five-year period of performance from May 2021 through April 2026.
Under the BPA, Pharmalucence will provide a range of radiopharmaceutical products to support nuclear medicine diagnostic imaging and related clinical...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement.
The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Alamo Nuclear Pharmacy Services Inc. on October 1, 2020, with a potential value of $400,000. The BPA provides for the delivery of radiopharmaceuticals to Army medical treatment facilities through September 30, 2025.
The originating sole source solicitation sought to procure stem cell transplant services for an urgent patient need at Brooke Army Medical Center. As the Regional Health Contracting...
Sofie CO. has been awarded a blanket purchase agreement by the Defense Health Agency to provide radiopharmaceuticals to various military treatment facilities. The single award BPA has a potential value of $700,000 and period of performance through September 2025. Sofie will supply specialized molecular imaging agents to support diagnostic imaging programs at locations including Fort Sam Houston in Texas.
Three calls have been placed against the BPA. In September 2023, Sofie received a $40,800...
The Blanket Purchase Agreement awarded by the Department of the Army Medical Command to Cardinal Health 414, LLC establishes a vehicle for procuring radiopharmaceutical supplies to support medical operations at Tripler Army Medical Center in Hawaii. The potential value of the BPA is $1,250,000 with a period of performance through April 2026.
Four calls have been placed against the Defense Health Agency's BPAs for nuclear and radiopharmaceutical products. Cardinal Health 414, LLC was awarded...
Cardinal Health 414, LLC Nphs Division has been awarded a single award, firm fixed price indefinite delivery contract by the Defense Health Agency to provide radiopharmaceuticals. The contract has a potential value of $563,789.91 over its five year period of performance from October 2021 through September 2026.
Under the contract, Cardinal Health will supply radiopharmaceutical products to support nuclear medicine procedures at military treatment facilities. Task orders will be issued against...
The Defense Health Agency awarded Curium US LLC a blanket purchase agreement for radiopharmaceutical products and services. Under multiple firm fixed price call contracts against the BPA, Curium will provide radiopharmaceuticals, supplies, and nuclear medicine services in support of DHA healthcare programs. Products and their delivery locations include radiopharmaceuticals to various military medical treatment facilities for $1M; radiopharmaceuticals and curium supplies in Fort Sam Houston,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA-VHA) awarded a blanket purchase agreement to Jubilant Draximage Radiopharmacies, Inc. doing business as Jubilant Radiopharma for the provision of radiopharmaceutical supplies. Under the single award agreement, which has a potential value of $1,379,724.67 and expires on March 31, 2028, the contractor may receive delivery orders for radiopharmaceuticals through April 30, 2024. The first...